The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2016
Filed:
Nov. 15, 2011
Applicants:
Oron Yacoby-zeevi, Moshav Bitsaron, IL;
Mara Nemas, Gedera, IL;
Inventors:
Oron Yacoby-Zeevi, Moshav Bitsaron, IL;
Mara Nemas, Gedera, IL;
Assignee:
NeuroDerm, Ltd., Rehovot, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 37/34 (2006.01); A61K 31/275 (2006.01); A01N 37/44 (2006.01); A61K 31/195 (2006.01); A61K 47/22 (2006.01); A61K 9/00 (2006.01); A61K 31/198 (2006.01); A61K 31/122 (2006.01); A61K 31/133 (2006.01); A61K 31/197 (2006.01); A61K 31/277 (2006.01); A61K 47/18 (2006.01); A61K 47/20 (2006.01);
U.S. Cl.
CPC ...
A61K 47/22 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 31/122 (2013.01); A61K 31/133 (2013.01); A61K 31/195 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/277 (2013.01); A61K 47/18 (2013.01); A61K 47/20 (2013.01);
Abstract
Provided herein, in part, is a method of treating a neurological or movement disorder in a patient in need thereof, comprising subcutaneously administering to said patient a pharmaceutically acceptable composition comprising levodopa and optionally carbidopa and optionally entacapone or tolcapone, or pharmaceutically acceptable salts thereof, wherein said composition is administered substantially continuously, and compositions that can be used in the disclosed methods.